Colorectal cancer is the fourth most common cancer in the UK and one of the leading causes of cancer-related deaths, affecting both the colon and rectum.
Symptoms often appear late when surgery is no longer an option according to the WHO.
inherited mutations (like BRCA2, CDKN2A, PALB2) account for about 10% of pancreatic cancers.
Survival rates in the UK are as low as 7.3% which is lower than the global average of ~12%.
Yearly, the number of deaths from this type of cancer are around 10,000.
Disclaimer! The information provided in this article is for educational purposes only and is based on NHS recommendations. It is not a substitute for professional medical advice. Always consult your doctor or a qualified healthcare provider for advice on medical conditions or treatments.
Pancreatic cancer is a disease where abnormal cells in the pancreas grow and divide uncontrollably. These cells can form a lump or tumour and may, in some cases, spread to other parts of the body. The pancreas is a gland located behind the stomach that helps with digestion and regulates blood sugar by producing hormones like insulin.
Most pancreatic cancers begin in the ducts of the pancreas (known as pancreatic ductal adenocarcinoma), but they can also start in the hormone-producing cells. Pancreatic cancer often develops without early warning signs, which can make it difficult to detect in the early stages. Like many cancers, early detection can greatly improve the chances of successful treatment.
If you have a family history of pancreatic cancer, or related cancers such as breast, ovarian, prostate, or melanoma, you may want to consider genetic testing. Inherited changes (mutations) in genes such as BRCA2, BRCA1, PALB2, CDKN2A, and ATM can significantly raise the risk of developing pancreatic cancer. Testing can help you find out whether you carry one of these mutations, offering important information for your future health and your family's.
You might be at higher risk if you have two or more close relatives who have had pancreatic cancer, if someone in your family was diagnosed at a young age (under 50), or if there is a known inherited condition like hereditary breast and ovarian cancer syndrome (HBOC) or Lynch syndrome. People of Ashkenazi Jewish descent are also at increased risk for certain inherited mutations. Research suggests that about 5–10% of pancreatic cancers are linked to inherited genetic changes. Understanding your genetic risk can open the door to earlier monitoring, preventative options, and personalised care plans.
These symptoms can be caused by many other conditions, but if they are new, persistent, or worsening, it is important to seek medical advice. Early diagnosis can improve treatment options and outcomes.
Pancreatic cancer can be caused by a combination of factors, including age (most cases occur in people over 65), smoking, obesity, diabetes, and family history. In many cases, no single cause can be identified.
Inherited genetic mutations account for about 5–10% of pancreatic cancers. Mutations in genes such as BRCA2, PALB2, ATM, and others significantly increase the lifetime risk of developing the disease. Genetic testing can identify these inherited risks early, giving you and your healthcare team the information needed to plan regular monitoring and possible preventative measures.
There are currently no routine screening programmes for pancreatic cancer in the general population. However, if you are at higher inherited risk, specialised screening may be recommended. This can include imaging tests like MRI scans, endoscopic ultrasounds (EUS), and blood tests for tumour markers such as CA19-9.
If you are concerned about a family history of pancreatic cancer, genetic testing can help identify mutations associated with increased risk. Knowing your genetic status allows for earlier intervention and tailored monitoring to help catch cancer at the earliest, most treatable stage.
Treatment for pancreatic cancer depends on the size, location, and stage of the tumour. Surgery to remove the tumour is often the preferred option where possible, sometimes combined with chemotherapy and radiotherapy to improve outcomes.
For individuals with inherited genetic mutations, treatment options may also include targeted therapies that specifically exploit weaknesses in cancer cells with certain genetic changes, such as PARP inhibitors for BRCA-related cancers. Your care team will work closely with you to develop a personalised treatment plan, focusing on achieving the best possible outcomes while maintaining quality of life.
We offer expert advice and testing for a range of genes that may increase your risk of developing certain types of cancer.
View Full Gene List
Genetic testing helps assess your cancer risk - explore the diagnostic tests we offer for a range of cancers
TruCheck™ Early Cancer Screening is a blood test that can detect early signs of multiple cancers before symptoms appear
We offer various blood test which can be markers for certain cancers, such as PSA, hCG, AFP, CA 19-9 and more
Book expert cancer investigations, such as colposcopy, smear tests, mammograms, MRI and ultrasound.
Recovering from cancer? Signatera is a revolutionary test that checks whether there are any residual cancer cells in your blood
Our team of expert Genetic Counsellors is here to help. Whether you're curious about testing, your results, or what’s right for you — we're just a message away.
Lorem ipsum dolor sit amet conse ctetur adip iscing elit justo quis odio sit sit ac port titor sit males dolor sit consectur dolor.
Lorem ipsum dolor sit amet conse ctetur adip iscing elit justo quis odio sit sit ac port titor sit males dolor sit consectur dolor.
Lorem ipsum dolor sit amet conse ctetur adip iscing elit justo quis odio sit sit ac port titor sit males dolor sit consectur dolor.
Lorem ipsum dolor sit amet conse ctetur adip iscing elit justo quis odio sit sit ac port titor sit males dolor sit consectur dolor.
Lorem ipsum dolor sit amet conse ctetur adip iscing elit justo quis odio sit sit ac port titor sit males dolor sit consectur dolor.
Lorem ipsum dolor sit amet conse ctetur adip iscing elit justo quis odio sit sit ac port titor sit males dolor sit consectur dolor.